David Westrip, Senior Biomedical Scientist and Deputy Chair of the British Society for Microbial Technology, provides a preview to its forthcoming annual microbiology conference.
AMR remains on the national risk register, which indicates drug-resistant infections are predicted to lead to 10 million deaths worldwide annually by 2050. The potential consequences within medicine are perhaps the most obvious where increased prevalence could impact areas such as routine surgery, and treatments such as chemotherapy may become more complicated. Clinical decision-making and patient care pathways will likely be affected and we could enter a scenario where some routine interventions will need to be re-evaluated as risks begin to outweigh potential benefits.
Resistance will inevitably increase if left unchecked. Nearly 100 years of well-documented antimicrobial usage has made that clear to anyone who has even a passing familiarity with the subject.
Click here to read the full article.
Image credit | Science-Photo-Library| Shutterstock
